In an increasingly globalized clinical research landscape, collaboration across borders, cultures, and regulatory frameworks has never been more critical. One organization at the forefront of this global integration is the MENASA Group a dynamic consortium dedicated to advancing healthcare, clinical research, and life sciences across the Middle East, North Africa, and South Asia (MENASA) region.
The MENASA Group serves as a strategic bridge between regional and global stakeholders, bringing together industry leaders, regulators, investigators, sponsors, CROs, academic institutions, and solution providers. With a mission rooted in collaboration, capacity building, and innovation, the organization focuses on strengthening clinical research ecosystems while promoting ethical, high quality, and patient centered research practices.
By fostering dialogue across diverse healthcare systems, the MENASA Group plays a vital role in addressing region specific challenges such as regulatory harmonization, workforce development, infrastructure readiness, and access to innovative therapies while aligning with international standards and best practices.

A cornerstone of the organization’s work is the highly anticipated MENASA Summit, an annual gathering designed to catalyze meaningful conversations and actionable partnerships within the global clinical research community. The Summit convenes experts from across the MENASA region and beyond, creating a collaborative forum where ideas, insights, and solutions take center stage.
The Summit’s agenda reflects the rapidly evolving clinical research environment, with a strong emphasis on innovation, diversity, and sustainable growth within emerging and established markets alike.
As clinical trials continue to expand into diverse geographies, the MENASA region represents both opportunity and responsibility. The MENASA Summit provides a unique platform to:
By uniting stakeholders under a shared vision, the Summit helps shape the future of clinical research in a way that is globally connected yet locally informed.
The MENASA Group’s commitment to collaboration and excellence positions it as a key driver of progress in the global research ecosystem. As anticipation builds for the upcoming MENASA Summit, one thing is clear: the conversations sparked and connections formed will extend far beyond the event itself contributing to stronger research partnerships, improved trial delivery, and better health outcomes worldwide.
Interim Visits Magazine looks forward to following the continued impact of the MENASA Group and sharing insights from the upcoming Summit with our readers.
Myra Fonville is the Executive Editor of Interim Visits magazine. Myra is a former pharmacist who has worked in the clinical research industry for the past 28 years. She brings a wealth of knowledge about pharmacy, pharmaceuticals and clinical research. Myra is very passionate about diversity and health equity which is one of the primary reasons Interim Visits is educating the public about the importance of clinical trials.